Experimental eye injection aims to reduce surgery complications
NCT ID NCT06926478
Summary
This early-stage trial is testing whether injecting the medication adalimumab (Humira) during artificial cornea surgery is safe and well-tolerated. It will involve 8 adults with severe corneal damage who are already scheduled for this specialized surgery. Researchers will monitor participants for 30 days after surgery to see if the injection helps reduce complications and inflammation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEVENS-JOHNSON SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts Eye and Ear
Boston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.